Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype?
- PMID: 15254408
- DOI: 10.4161/cbt.3.7.1057
Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype?
Abstract
Tumor cells frequently recruit the PI3K/Akt pathway in order to evade cell death, terminal differentiation and replicative inhibition. A wealth of targets for the PI3K/Akt pathway involved in these processes has been described. Among others, targets for the Akt-kinase include certain members of the Forkhead Box Class O (FOXO) transcription factors, involved in DNA damage repair, apoptosis, cell cycle progression and arrest. Akt regulates the sub-cellular localization of FOXO3a by phosphorylation thereby preventing the protein to translocate to the nucleus and regulate transcription. Constitutive Akt-activation is frequently correlated with cytoplasmatic FOXO3a in breast tumors and this is associated with decreased patient survival. In a recent paper (Hu MC, et al. Cell 2004; 117:225-237) FOXO3a was found in the cytoplasm in the absence of activated Akt. Instead, IKKbeta was shown to interact with and phosphorylate FOXO3a. The recent findings suggest that the IKKs might serve as a potential drug target in anti-cancer therapy since multiple signal transduction pathways inhibiting proliferation and facilitating cell death could be activated.
Similar articles
-
Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).Mol Cell Biol. 2001 Feb;21(3):952-65. doi: 10.1128/MCB.21.3.952-965.2001. Mol Cell Biol. 2001. PMID: 11154281 Free PMC article.
-
IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.Cell. 2004 Apr 16;117(2):225-37. doi: 10.1016/s0092-8674(04)00302-2. Cell. 2004. PMID: 15084260
-
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.Mol Cell Biol. 2004 Oct;24(19):8681-90. doi: 10.1128/MCB.24.19.8681-8690.2004. Mol Cell Biol. 2004. PMID: 15367686 Free PMC article.
-
FOXO transcription factors in cell-cycle regulation and the response to oxidative stress.Antioxid Redox Signal. 2005 May-Jun;7(5-6):752-60. doi: 10.1089/ars.2005.7.752. Antioxid Redox Signal. 2005. PMID: 15890021 Review.
-
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.Annu Rev Immunol. 2000;18:621-63. doi: 10.1146/annurev.immunol.18.1.621. Annu Rev Immunol. 2000. PMID: 10837071 Review.
Cited by
-
The Relationship between Oxidative Status and Radioiodine Treatment Qualification among Papillary Thyroid Cancer Patients.Cancers (Basel). 2023 Apr 24;15(9):2436. doi: 10.3390/cancers15092436. Cancers (Basel). 2023. PMID: 37173902 Free PMC article.
-
The FOXO family of transcription factors: key molecular players in gastric cancer.J Mol Med (Berl). 2022 Jul;100(7):997-1015. doi: 10.1007/s00109-022-02219-x. Epub 2022 Jun 10. J Mol Med (Berl). 2022. PMID: 35680690 Review.
-
Sera from women with different metabolic and menopause states differentially regulate cell viability and Akt activation in a breast cancer in-vitro model.PLoS One. 2022 Apr 12;17(4):e0266073. doi: 10.1371/journal.pone.0266073. eCollection 2022. PLoS One. 2022. PMID: 35413055 Free PMC article.
-
ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen.Cancers (Basel). 2020 Mar 27;12(4):802. doi: 10.3390/cancers12040802. Cancers (Basel). 2020. PMID: 32230714 Free PMC article.
-
Post-translational modification of Parkin and its research progress in cancer.Cancer Commun (Lond). 2019 Nov 21;39(1):77. doi: 10.1186/s40880-019-0421-5. Cancer Commun (Lond). 2019. PMID: 31753025 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
